A patient nearly lost her life after taking a compounded version of a GLP-1 drug. Not bought online. Not from the street but prescribed and dispensed by a compounded pharmacy. This must-read Washington Post op-ed is a stark reminder of a parallel drug market hiding in plain sight, out of control and threatening lives.
Today we’re seeing large-scale production of copycat versions of complex medicines without FDA pre-market review, without verified quality standards, and often with ingredients sourced through opaque global supply chains. That’s not personalization. That’s a workaround and a prescription for disaster.
The FDA has been clear: it cannot verify the safety, quality, or effectiveness of unapproved mass compounded drugs. And yet these products are being aggressively marketed with a wink and a nod as if they are interchangeable with FDA-approved therapies. “Essentially a copy?” – give me a break. And for shame on the pharmacies that peddle these mistruths, half-truths and outright lies.
https://www.washingtonpost.com/opinions/2026/03/31/weight-loss-compounding-pharmacies/
Today we’re seeing large-scale production of copycat versions of complex medicines without FDA pre-market review, without verified quality standards, and often with ingredients sourced through opaque global supply chains. That’s not personalization. That’s a workaround and a prescription for disaster.
The FDA has been clear: it cannot verify the safety, quality, or effectiveness of unapproved mass compounded drugs. And yet these products are being aggressively marketed with a wink and a nod as if they are interchangeable with FDA-approved therapies. “Essentially a copy?” – give me a break. And for shame on the pharmacies that peddle these mistruths, half-truths and outright lies.
https://www.washingtonpost.com/opinions/2026/03/31/weight-loss-compounding-pharmacies/
